Fresno, CANCT06129240Now EnrollingIRB Ready

Pulmonary Hypertension Clinical Trial in Fresno, CA

Access cutting-edge pulmonary hypertension treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.

Sponsored by Liquidia Technologies, Inc.

Quick Self-Assessment

See if you qualify for this Fresno location

Preparing your pre-screening questions…

Expert Care in Fresno

Access pulmonary hypertension specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary hypertension treatment provided free

Apply for This Fresno Location

Check if you qualify for this pulmonary hypertension clinical trial in Fresno, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fresno

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fresno site if eligible
  4. 4Begin participation

About This Pulmonary Hypertension Study in Fresno

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

Sponsor: Liquidia Technologies, Inc.

Who Can Participate

Inclusion Criteria

Males or Females between 18 years to 80 years of age.
Has a confirmed diagnosis of WHO Group 3 PH-ILD based on CT chest imaging performed, which demonstrates evidence of diffuse parenchymal lung disease and FEV1/FVC (absolute values) ≥ 70% and are required to have evidence of pulmonary hypertension (PH) as demonstrated from right heart catheterization (RHC) with the following hemodynamic parameters.
i) Pulmonary vascular resistance (PVR) ≥ 3 Wood Units (WU) and ii) Pulmonary capillary wedge pressure (PCWP) of ≤ 15 mmHg and iii) A mean pulmonary arterial pressure (mPAP) of ≥ 30 mmHg. OR
An exploratory subset of subjects with ILD: i) Pulmonary vascular resistance (PVR) ≥ 3 Wood Units (WU) and ii) Pulmonary capillary wedge pressure (PCWP) of ≤ 15 mmHg and iii) A mean pulmonary arterial pressure (mPAP) of ≥ 21 mmHg.
6-minute walk distance of ≥ 125 meters Cohort A Key

Exclusion Criteria

A Subject is not eligible for inclusion in the study if any of the following criteria apply:
PH in the Updated WHO Classification Groups 1, 2, 4, or 5.
History of hemodynamically significant left-sided heart disease.
Exacerbation of underlying lung disease or active pulmonary or upper respiratory infections.
Initiation of pulmonary rehabilitation. Cohort B Key Inclusion Criteria
Male or Females between 18 years to 75 years of age at Screening.
Has a diagnosis of WHO Group 3 PH-ILD confirmed with CT chest imaging performed at the screening visit, which demonstrates evidence of diffuse parenchymal lung disease and FEV1/FVC (absolute values) ≥70%. Subjects are required to have evidence of pulmonary hypertension (PH) as demonstrated from right heart catheterization (RHC) with the following documented parameters:
Pulmonary vascular resistance (PVR) ≥3 Wood Units (WU) and
Pulmonary capillary wedge pressure (PCWP) of ≤ 15 mmHg and
A mean pulmonary arterial pressure (mPAP) of ≥ 25 mmHg
Subjects must be on protocol specified dose of inhaled treprostinil QID not at treatment goal, and able to transition from their prescribed dose of inhaled Treprostinil therapy to LIQ861.
6-minute walk distance of ≥ 200 meters Cohort B Key Exclusion Criteria
PH in the Updated WHO Classification Groups 1, 2, 4, or 5.
Inability to titrate inhaled treprostinil above 5 breaths (Tyvaso®) or above 16 mcg Tyvaso DPI®.
History of Bronchospasm with Tyvaso or Tyvaso DPI.
History of persistent moderate asthma or severe asthma.
History of hemodynamically significant left-sided heart disease.
Exacerbation of underlying lung disease or active pulmonary or upper respiratory infections.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fresno?

Yes, this clinical trial (NCT06129240) has an active research site in Fresno, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Hypertension Treatment Options in Fresno, CA

If you're searching for pulmonary hypertension treatment options in Fresno, CA, this clinical trial (NCT06129240) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary hypertension clinical trials near you to find additional studies recruiting in your area.

More Hypertension Trials in Fresno, CA

See all hypertension clinical trials recruiting in Fresno — not just this study.

Browse Hypertension Trials in Fresno →

Browse More Trials by Condition

Hypertension TrialsPulmonary Embolism TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Fresno?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fresno, CA